C3 and cancer: MMP-mediated type III collagen degradation (C3M) was significantly elevated in cancer patients compared to healthy controls (p < 0.0001), whereas type III collagen formation (PRO-C3) was borderline elevated in the cancer patients (p = 0.063) (Figure 2a,b).